VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,749,221 | -12.4% | 65,003 | -2.0% | 0.03% | -10.0% |
| Q2 2023 | $1,996,500 | -36.9% | 66,307 | -32.2% | 0.03% | -41.2% |
| Q1 2023 | $3,165,948 | +10.6% | 97,865 | -2.1% | 0.05% | +4.1% |
| Q4 2022 | $2,863,602 | +59.4% | 99,916 | +34.1% | 0.05% | +44.1% |
| Q3 2022 | $1,797,000 | -65.6% | 74,503 | -60.9% | 0.03% | -64.6% |
| Q2 2022 | $5,218,000 | +8.1% | 190,587 | +51.4% | 0.10% | +28.0% |
| Q1 2022 | $4,829,000 | +94.5% | 125,919 | +62.4% | 0.08% | +97.4% |
| Q4 2021 | $2,483,000 | +12.3% | 77,536 | +3.3% | 0.04% | 0.0% |
| Q3 2021 | $2,211,000 | -54.4% | 75,038 | -47.5% | 0.04% | -53.7% |
| Q2 2021 | $4,853,000 | -99.9% | 142,806 | -44.7% | 0.08% | +10.8% |
| Q1 2021 | $8,399,358,000 | +125076.7% | 258,442 | +38.7% | 0.07% | -49.0% |
| Q4 2020 | $6,710,000 | -34.8% | 186,294 | -29.1% | 0.14% | -44.0% |
| Q3 2020 | $10,291,000 | +6.9% | 262,799 | +0.2% | 0.26% | -5.5% |
| Q2 2020 | $9,623,000 | +135.4% | 262,359 | +47.9% | 0.27% | +82.7% |
| Q1 2020 | $4,088,000 | -14.3% | 177,440 | +8.9% | 0.15% | +6.4% |
| Q4 2019 | $4,769,000 | +4.0% | 162,896 | -5.1% | 0.14% | -8.4% |
| Q3 2019 | $4,584,000 | +302.1% | 171,624 | +284.7% | 0.15% | +266.7% |
| Q2 2019 | $1,140,000 | -67.4% | 44,618 | -71.4% | 0.04% | -71.6% |
| Q1 2019 | $3,492,000 | +8.3% | 155,775 | +1.9% | 0.15% | -5.7% |
| Q4 2018 | $3,224,000 | +167.6% | 152,887 | +135.0% | 0.16% | +175.4% |
| Q3 2018 | $1,205,000 | +14.2% | 65,063 | +37.6% | 0.06% | -9.5% |
| Q2 2018 | $1,055,000 | +5.0% | 47,282 | +3.4% | 0.06% | -8.7% |
| Q1 2018 | $1,005,000 | -46.9% | 45,724 | -43.9% | 0.07% | -52.4% |
| Q4 2017 | $1,894,000 | +851.8% | 81,505 | +840.2% | 0.14% | +625.0% |
| Q3 2017 | $199,000 | +134.1% | 8,669 | +124.8% | 0.02% | +100.0% |
| Q2 2017 | $85,000 | -5.6% | 3,856 | -2.5% | 0.01% | -28.6% |
| Q1 2017 | $90,000 | +23.3% | 3,956 | +12.8% | 0.01% | -57.6% |
| Q4 2016 | $73,000 | – | 3,506 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |